Tracy Hubert says in a small community like Guernsey's, she's not seen many people speak openly about their experiences of a ...
University of Colorado Cancer Center member Matthew Sikora, Ph.D., is a national leader in research into an understudied subtype of breast cancer that's on the rise in American women, is often more ...
October is Breast Cancer Awareness month, which means it’s common to see pink ribbons everywhere as health advocates call for ...
Stage 0 cancer, or carcinoma in situ, represents the earliest detectable phase where abnormal cells are confined to their ...
Stage 0 cancer, known as carcinoma in situ, marks the earliest stage of cancer development. Abnormal cells are present but ...
As an avid cyclist and emergency room nurse at Murray-Calloway County Hospital, Kiki Cunningham-Canerdy said that the last ...
For women with in situ breast disease, the 313-single nucleotide polymorphism breast cancer polygenic risk score (PRS313) can predict the likelihood of developing future breast cancer.
Cairn Surgical, Inc., an innovative medical technology firm striving to make breast cancer surgery more precise, announced today that a multicenter study just published in the November issue of the ...
Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines in oncology, today announced that Laura J. Esserman, MD ...
According to the American Cancer Society, the average American man has a 1 in 726 chance of getting diagnosed with breast ...
Breast cancer affects 1 in 7 Australian women — but survival now exceeds 90% thanks to early detection and treatment.
Milspouses have advantages in fighting breast cancer: family, community, and TRICARE. Here's how an Army vet and Air Force ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback